0001062993-22-004450.txt : 20220215
0001062993-22-004450.hdr.sgml : 20220215
20220215161331
ACCESSION NUMBER: 0001062993-22-004450
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220214
FILED AS OF DATE: 20220215
DATE AS OF CHANGE: 20220215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Parker Albert P
CENTRAL INDEX KEY: 0001750079
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37526
FILM NUMBER: 22639309
MAIL ADDRESS:
STREET 1: C/O ONCOCYTE CORPORATION
STREET 2: 1010 ATLANTIC AVENUE, SUITE 102
CITY: ALAMEDA
STATE: CA
ZIP: 94501
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zynerba Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001621443
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 260389433
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 80 W. LANCASTER AVENUE
STREET 2: SUITE 300
CITY: DEVON
STATE: PA
ZIP: 19333
BUSINESS PHONE: 484-581-7505
MAIL ADDRESS:
STREET 1: 80 W. LANCASTER AVENUE
STREET 2: SUITE 300
CITY: DEVON
STATE: PA
ZIP: 19333
FORMER COMPANY:
FORMER CONFORMED NAME: Zynerba Pharmeceuticals, Inc.
DATE OF NAME CHANGE: 20141003
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2022-02-14
0001621443
Zynerba Pharmaceuticals, Inc.
ZYNE
0001750079
Parker Albert P
C/O ZYNERBA PHARMACEUTICALS, INC.
80 W. LANCASTER AVENUE, SUITE 300
DEVON
PA
19333
0
1
0
0
Chief Legal Officer
Common Stock
2022-02-14
4
A
0
35000
0
A
35000
D
Stock Option (right to buy)
2.70
2022-02-14
4
A
0
200000
0
A
2032-02-14
Common Stock
200000
200000
D
The restricted stock award vests in 3 equal annual installments on the first, second, and third anniversaries of the date of grant, beginning on February 14, 2023.
The stock option vests 25% on the first anniversary of the date of the grant, with the remainder vesting in 12 equal quarterly installments thereafter, subject to continued employment with the Company through the applicable vesting date.
/s/ Albert P. Parker
2022-02-15